Share on StockTwits

Cyberonics (NASDAQ:CYBX) VP Darren Alch unloaded 1,750 shares of the stock in a transaction that occurred on Monday, February 24th. The stock was sold at an average price of $69.19, for a total value of $121,082.50. Following the completion of the transaction, the vice president now directly owns 18,874 shares in the company, valued at approximately $1,305,892. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link.

A number of analysts have recently weighed in on CYBX shares. Analysts at Citigroup Inc. reiterated a “buy” rating on shares of Cyberonics in a research note on Friday, February 21st. They now have a $85.00 price target on the stock, up previously from $80.00. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Cyberonics in a research note on Tuesday, December 24th. They now have a $67.00 price target on the stock. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $64.29.

Cyberonics (NASDAQ:CYBX) traded down 0.80% during mid-day trading on Wednesday, hitting $68.20. The stock had a trading volume of 74,217 shares. Cyberonics has a 1-year low of $42.49 and a 1-year high of $73.52. The stock has a 50-day moving average of $68.20 and a 200-day moving average of $60.40. The company has a market cap of $1.839 billion and a P/E ratio of 39.51.

Cyberonics (NASDAQ:CYBX) last released its earnings data on Thursday, February 20th. The company reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.49 by $0.02. The company had revenue of $68.20 million for the quarter, compared to the consensus estimate of $69.65 million. On average, analysts predict that Cyberonics will post $2.04 earnings per share for the current fiscal year.

Cyberonics, Inc (NASDAQ:CYBX) is a medical device company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.